Prerna Mewawalla, Myeloma and Transplant Physician, Associate Professor at Drexel University College of Medicine, shared a post on LinkedIn:
“In this Vumedi video, I discuss “Myeloma Bispecifics in Practice: Efficacy, Safety, and Bringing Care Closer to Home”, a review of currently available bispecific antibodies, emerging agents in clinical trials, including cevostamab, and practical considerations for incorporating them into real-world care.
As bispecifics move earlier in the disease course, our ability to standardize outpatient initiation, infection prevention, monitoring, escalation pathways, and community-based access will determine their real-world impact.
Watch here.”